Trial Profile
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 18 Aug 2023
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Therapeutic Use
- 26 Sep 2013 M.D. Anderson Cancer Center record reports trial status as active, no longer recruiting.
- 15 Aug 2012 New source identified and integrated (M.D. Anderson Cancer Center record, NSABP-P5).
- 27 Jan 2012 Additional trial location (Canada) identified as reported by ClinicalTrials.gov.